Is there a generic for Trimetrexate glucuronate?

The FDA Orange Book does not currently list an approved generic (ANDA) for Trimetrexate glucuronate. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Trimetrexate glucuronate?

NEUTREXIN (NDA 020326, MEDIMMUNE ONCOLOGY) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Trimetrexate glucuronate are approved?

Trimetrexate glucuronate is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Trimetrexate glucuronate

Trimetrexate glucuronate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:NEUTREXIN · NDA 020326

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
NEUTREXIN×2	MEDIMMUNE ONCOLOGY	NDA 020326	—	Dec 17, 1993

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Trimetrexate glucuronate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo